BLACR
Bellevue Life Sciences Acquisition Corp. Rights
BLACR
BLACR
Delisted
BLACR was delisted on the 14th of February, 2025.
30 hedge funds and large institutions have $562K invested in Bellevue Life Sciences Acquisition Corp. Rights in 2024 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
30
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$25K | |
| 2 | +$7.39K | |
| 3 | +$2.73K | |
| 4 |
FTUS
Flow Traders U.S.
New York
|
+$184 |
Top Sellers
| 1 | -$50.4K | |
| 2 | -$17.1K | |
| 3 | -$9.88K | |
| 4 |
EAM
Exos Asset Management
New York
|
-$2.13K |
| 5 |
CCM
Condor Capital Management
Martinsville,
New Jersey
|
-$1.41K |